Stocktwits on MSN
Why did EBS stock fall 13% today?
Shares of Emergent Biosolutions Inc (EBS) slumped 13% on Thursday after New York State Attorney General Letitia James sued ...
Emergent BioSolutions is a key player in public health. Its flagship product, NARCAN, is central to combating the opioid crisis. EBS stock rally is likely driven by its smallpox vaccine, ACAM2000, ...
Emergent BioSolutions delivered a strong Q2 2025, beating its own guidance and showing major improvements in margins. EBS has a sound turnaround strategy that is showing signs of success. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results